| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |